Compounds > aspartic acid
Page last updated: 2024-08-17

aspartic acid and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

aspartic acid has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Regan, MH; Perkins, LM; Phillis, JW; Simpson, RE1
Bianchi, L; Corsi, C; Melani, A; Pedata, F; Pepeu, G1
Agostinho, P; Caseiro, P; Cunha, RA; Duarte, EP; Oliveira, CR; Rego, AC1
Dohovics, R; Janáky, R; Oja, SS; Saransaari, P; Varga, V1
Agostinho, P; Augusto, E; Chen, JF; Cunha, RA; Matos, M1

Other Studies

5 other study(ies) available for aspartic acid and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine

ArticleYear
The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex.
    Neuroscience letters, 1992, Apr-13, Volume: 138, Issue:1

    Topics: Adenosine; Analysis of Variance; Animals; Antihypertensive Agents; Aspartic Acid; Cerebral Cortex; Glutamates; Glutamic Acid; Ischemic Attack, Transient; Kinetics; Male; Phenethylamines; Rats; Rats, Wistar; Receptors, Purinergic

1992
Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats.
    Neuroreport, 1999, Mar-17, Volume: 10, Issue:4

    Topics: Adenosine; Aging; Animals; Aspartic Acid; Extracellular Space; Glutamic Acid; Male; Microdialysis; Neostriatum; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1

1999
Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
    Neurochemistry international, 2000, Volume: 36, Issue:3

    Topics: Adenosine; Adenosine Deaminase; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Cells, Cultured; Chick Embryo; Drug Synergism; Kinetics; Oxidative Stress; Phenethylamines; Potassium; Potassium Chloride; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Retina; Theobromine; Tritium; Xanthines

2000
Changes in intracellular cyclic AMP formation mask opposing modulation of kainate-enhanced glutamate release in the striatum.
    Proceedings of the Western Pharmacology Society, 2004, Volume: 47

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adrenergic beta-Agonists; Alloxan; Animals; Aspartic Acid; Cyclic AMP; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Isoproterenol; Kainic Acid; Kinetics; Mice; Neostriatum; Phenethylamines

2004
Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Nov-20, Volume: 33, Issue:47

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Aspartic Acid; Astrocytes; Glial Fibrillary Acidic Protein; Glutamic Acid; Immunoprecipitation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ouabain; Phenethylamines; Pyrimidines; Receptor, Adenosine A2A; Sodium-Potassium-Exchanging ATPase; Subcellular Fractions; Triazoles; Tritium

2013